{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:52:52Z","timestamp":1780501972930,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HE 7607\/1.1"],"award-info":[{"award-number":["HE 7607\/1.1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002345","name":"Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jgar.2020.11.024","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T12:44:29Z","timestamp":1607345069000},"page":"93-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["In vitro activity of eravacycline, a novel synthetic halogenated tetracycline, against the malaria parasite Plasmodium falciparum"],"prefix":"10.1016","volume":"24","author":[{"given":"Erik","family":"Koehne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kreidenweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayode Romeo","family":"Adegbite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rella Zoleko","family":"Manego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.B.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghyslain","family":"Mombo-Ngoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayola Akim","family":"Adegnika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9lidji Todagb\u00e9","family":"Agnandji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Mordm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2020.11.024_bib0005","series-title":"World malaria report 2019","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.jgar.2020.11.024_bib0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2020.11.024_bib0015","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2020.11.024_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6502a1","article-title":"Diagnosis and management of tickborne rickettsial diseases: rocky mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States a practical guide for health care and public health professionals","volume":"65","author":"Biggs","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jgar.2020.11.024_bib0025","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/jama.2016.2884","article-title":"Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review","volume":"315","author":"Sanchez","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2020.11.024_bib0030","series-title":"2015 STD treatment guidelines","year":"2015"},{"key":"10.1016\/j.jgar.2020.11.024_bib0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s12936-015-0980-0","article-title":"Tetracyclines in malaria","volume":"14","author":"Gaillard","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2020.11.024_bib0040","series-title":"Centers for disease control and prevention","year":"2018"},{"key":"10.1016\/j.jgar.2020.11.024_bib0045","series-title":"Guidelines for the treatment of malaria","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.jgar.2020.11.024_bib0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.molbiopara.2007.01.005","article-title":"The effects of anti-bacterials on the malaria parasite Plasmodium falciparum","volume":"152","author":"Goodman","year":"2007","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2020.11.024_bib0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrmicro2333","article-title":"How antibiotics kill bacteria: from targets to networks","volume":"8","author":"Kohanski","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jgar.2020.11.024_bib0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3831\/KPI.2016.19.001","article-title":"Anti-malarial drug design by targeting apicoplasts: new perspectives","volume":"19","author":"Mukherjee","year":"2016","journal-title":"J Pharmacopuncture"},{"key":"10.1016\/j.jgar.2020.11.024_bib0065","first-page":"3490","article-title":"The apicoplast: a key target to cure malaria","volume":"18","author":"MacRae","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jgar.2020.11.024_bib0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpara.2016.08.005","article-title":"The apicoplast: now you see it, now you don\u2019t","volume":"47","author":"McFadden","year":"2017","journal-title":"Int J Par"},{"key":"10.1016\/j.jgar.2020.11.024_bib0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40265-016-0545-8","article-title":"Review of eravacycline, a novel fluorocycline antibacterial agent","volume":"76","author":"Zhanel","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.jgar.2020.11.024_bib0080","first-page":"155","article-title":"Tigecycline (Tygacil): the first in the glycylcycline class of antibiotics","volume":"19","author":"Greer","year":"2006","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.jgar.2020.11.024_bib0085","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1128\/AAC.01288-13","article-title":"Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens","volume":"57","author":"Sutcliffe","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.11.024_bib0090","series-title":"FDA awards fast track status to tetraphase pharmaceuticals for IV and oral formulations of eravacycline [news release]","article-title":"Tetraphase pharmaceuticals","year":"2014"},{"key":"10.1016\/j.jgar.2020.11.024_bib0095","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijantimicag.2010.02.003","article-title":"In vitro activity of tigecycline in Plasmodium falciparum culture-adapted strains and clinical isolates from Gabon","volume":"35","author":"Held","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.11.024_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078661","article-title":"2A and the auxin-based degron system facilitate control of protein levels in Plasmodium falciparum","volume":"8","author":"Kreidenweiss","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2020.11.024_bib0105","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J Parasitol"},{"key":"10.1016\/j.jgar.2020.11.024_bib0110","doi-asserted-by":"crossref","first-page":"17336","DOI":"10.1038\/s41598-019-53912-w","article-title":"Histone deacetylase inhibitors with high in vitro activities against Plasmodium falciparum isolates collected from Gabonese children and adults","volume":"9","author":"Koehne","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2020.11.024_bib0115","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1128\/AAC.03326-14","article-title":"Antimalarial activity of the myxobacterial macrolide chlorotonil A","volume":"58","author":"Held","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.11.024_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001138","article-title":"Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum","author":"Yeh","year":"2011","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jgar.2020.11.024_bib0125","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1128\/AAC.49.8.3575-3577.2005","article-title":"Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing","volume":"49","author":"Noedl","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.11.024_bib0130","series-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2013"},{"key":"10.1016\/j.jgar.2020.11.024_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001138","article-title":"Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum","volume":"9","author":"Yeh","year":"2011","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jgar.2020.11.024_bib0140","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12936-019-2972-y","article-title":"DNA recovery from archived RDTs for genetic characterization of Plasmodium falciparum in a routine setting in Lambar\u00e9n\u00e9, Gabon","volume":"18","author":"Nguyen","year":"2019","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2020.11.024_bib0145","doi-asserted-by":"crossref","first-page":"9784","DOI":"10.1038\/s41598-019-46194-9","article-title":"Characterization of Plasmodium infections among inhabitants of rural areas in Gabon","volume":"9","author":"Woldearegai","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2020.11.024_bib0150","series-title":"Xerava: highlights of prescribing information","year":"2019"},{"key":"10.1016\/j.jgar.2020.11.024_bib0155","doi-asserted-by":"crossref","first-page":"41303","DOI":"10.1038\/srep41303","article-title":"Culture adaptation of malaria parasites selects for convergent loss-of-function mutants","volume":"7","author":"Claessens","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2020.11.024_bib0160","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00527-07","article-title":"Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast","volume":"51","author":"Dahl","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.11.024_bib0165","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/AAC.01090-09","article-title":"In vitro activity of mirincamycin (U24729A) against Plasmodium falciparum isolates from Gabon","volume":"54","author":"Held","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.11.024_bib0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0166-6851(89)90002-9","article-title":"Mitochondria as the site of action of tetracycline on Plasmodium falciparum","volume":"34","author":"Kiatfuengfoo","year":"1989","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2020.11.024_bib0175","series-title":"World Guidelines for the treatment of malaria 2015","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.jgar.2020.11.024_bib0180","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.pt.2009.09.001","article-title":"ABC - antibiotics-based combinations for the treatment of severe malaria?","volume":"25","author":"Noedl","year":"2009","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jgar.2020.11.024_bib0185","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1128\/AAC.46.8.2315-2320.2002","article-title":"Clindamycin as an antimalarial drug: review of clinical trials","volume":"46","author":"Lell","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.11.024_bib0190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2875-11-2","article-title":"Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis","volume":"11","author":"Obonyo","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2020.11.024_bib0195","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/AAC.00312-09","article-title":"Antimalarial activity of tigecycline, a novel glycylcycline antibiotic","volume":"53","author":"Starzengruber","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.11.024_bib0200","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1177\/1060028019850173","article-title":"Eravacycline: the tetracyclines strike back","volume":"53","author":"Heaney","year":"2019","journal-title":"Ann Pharmacother"}],"updated-by":[{"DOI":"10.1016\/j.jgar.2022.10.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000}}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520303106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520303106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:22:45Z","timestamp":1778858565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716520303106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":40,"alternative-id":["S2213716520303106"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2020.11.024","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of eravacycline, a novel synthetic halogenated tetracycline, against the malaria parasite Plasmodium falciparum","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2020.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}